Credit Suisse’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $455K | Buy |
+44,599
| New | +$455K | ﹤0.01% | 2670 |
|
2023
Q2 | – | Sell |
-41,372
| Closed | -$175K | – | 3150 |
|
2023
Q1 | $175K | Buy |
41,372
+3,235
| +8% | +$13.7K | ﹤0.01% | 3127 |
|
2022
Q4 | $627K | Buy |
+38,137
| New | +$627K | ﹤0.01% | 2623 |
|
2022
Q3 | – | Sell |
-21
| Closed | – | – | 4005 |
|
2022
Q2 | $0 | Buy |
+21
| New | – | ﹤0.01% | 3880 |
|
2021
Q4 | – | Sell |
-1,410,397
| Closed | -$16M | – | 3613 |
|
2021
Q3 | $16M | Sell |
1,410,397
-19,378
| -1% | -$219K | 0.01% | 900 |
|
2021
Q2 | $14.1M | Buy |
1,429,775
+515,336
| +56% | +$5.08M | 0.01% | 991 |
|
2021
Q1 | $12.9M | Sell |
914,439
-279,280
| -23% | -$3.95M | 0.01% | 1049 |
|
2020
Q4 | $13.5M | Buy |
+1,193,719
| New | +$13.5M | 0.01% | 987 |
|
2017
Q3 | – | Sell |
-449
| Closed | -$43K | – | 3674 |
|
2017
Q2 | $43K | Buy |
+449
| New | +$43K | ﹤0.01% | 3394 |
|
2017
Q1 | – | Sell |
-263
| Closed | -$256K | – | 3414 |
|
2016
Q4 | $256K | Buy |
263
+184
| +233% | +$179K | ﹤0.01% | 3362 |
|
2016
Q3 | $68K | Sell |
79
-10
| -11% | -$8.61K | ﹤0.01% | 3638 |
|
2016
Q2 | $65K | Buy |
+89
| New | +$65K | ﹤0.01% | 3814 |
|
2015
Q2 | – | Sell |
-85
| Closed | -$42K | – | 4208 |
|
2015
Q1 | $42K | Buy |
+85
| New | +$42K | ﹤0.01% | 4007 |
|